Jul 27, 2026 08:06AM
Jul 27, 2026 08:05AM
Jun 30, 2026 08:06AM
Jun 30, 2026 08:05AM
May 28, 2026 08:05AM
May 28, 2026 08:05AM
May 27, 2026 08:05AM Aptevo and Niowave form partnership for cancer drug development
May 27, 2026 08:05AM
May 13, 2026 08:07AM
May 13, 2026 08:05AM
May 6, 2026 08:10AM
May 6, 2026 08:05AM
Mar 26, 2026 08:05AM
Mar 19, 2026 08:05AM Aptevo to Participate in March 2026 Conferences
Mar 10, 2026 08:21AM
Mar 10, 2026 08:05AM
Feb 3, 2026 08:06AM
Feb 3, 2026 08:05AM
Jan 28, 2026 04:23PM
Jan 9, 2026 08:05AM
Jan 9, 2026 08:05AM Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
Dec 26, 2025 08:05AM
Dec 26, 2025 08:05AM
Dec 9, 2025 08:07AM
Dec 9, 2025 08:05AM
Nov 10, 2025 08:05AM
Nov 10, 2025 08:05AM
Nov 6, 2025 08:05AM Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update
Oct 8, 2025 08:20AM
Oct 1, 2025 04:34PM
Sep 16, 2025 08:34AM
Sep 16, 2025 08:30AM
Sep 5, 2025 09:00AM
Sep 4, 2025 08:46AM
Sep 4, 2025 08:45AM Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules
Aug 13, 2025 08:06AM
Aug 13, 2025 08:05AM
Aug 11, 2025 10:53AM
Aug 11, 2025 08:05AM
Aug 8, 2025 09:00AM
Jul 25, 2025 04:18PM
Jun 20, 2025 11:30AM Aptevo Therapeutics (APVO) Announces Closing of $8 Million Offering
Jun 20, 2025 11:30AM
Jun 20, 2025 08:55AM
Jun 20, 2025 08:55AM
Jun 18, 2025 10:53AM
Jun 18, 2025 10:52AM
Jun 18, 2025 10:52AM
Jun 18, 2025 08:07AM Aptevo Therapeutics (APVO): Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML
Jun 18, 2025 08:01AM

435,230 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All